Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | +3.05K | +14.3% | 24.3K | May 4, 2023 | Direct | F1 | ||
transaction | OGN | Common Stock | Tax liability | -$25.3K | -1.04K | -4.29% | $24.24 | 23.3K | May 4, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -3.05K | -49.98% | $0.00 | 3.05K | May 4, 2023 | Common Stock | 3.05K | Direct | F1 |
Id | Content |
---|---|
F1 | 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. |